These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23838031)

  • 1. Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions.
    Dolisca SB; Mehta M; Pearce DA; Mink JW; Maria BL
    J Child Neurol; 2013 Sep; 28(9):1074-100. PubMed ID: 23838031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.
    Cooper JD
    Curr Opin Neurol; 2003 Apr; 16(2):121-8. PubMed ID: 12644737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large animal models for Batten disease: a review.
    Weber K; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1123-7. PubMed ID: 24014507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic landscape for Batten disease: current treatments and future prospects.
    Johnson TB; Cain JT; White KA; Ramirez-Montealegre D; Pearce DA; Weimer JM
    Nat Rev Neurol; 2019 Mar; 15(3):161-178. PubMed ID: 30783219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease).
    Mitchison HM; Mole SE
    Curr Opin Neurol; 2001 Dec; 14(6):795-803. PubMed ID: 11723391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Batten disease: four genes and still counting.
    Mole SE
    Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
    Bond M; Holthaus SM; Tammen I; Tear G; Russell C
    Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCL disease mechanisms.
    Palmer DN; Barry LA; Tyynelä J; Cooper JD
    Biochim Biophys Acta; 2013 Nov; 1832(11):1882-93. PubMed ID: 23707513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses.
    Morsy A; Carmona AV; Trippier PC
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases.
    Bennett MJ; Hofmann SL
    J Inherit Metab Dis; 1999 Jun; 22(4):535-44. PubMed ID: 10407785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal ceroid-lipofuscinoses.
    Haltia M
    J Neuropathol Exp Neurol; 2003 Jan; 62(1):1-13. PubMed ID: 12528813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and natural history of the neuronal ceroid lipofuscinoses.
    Mink JW; Augustine EF; Adams HR; Marshall FJ; Kwon JM
    J Child Neurol; 2013 Sep; 28(9):1101-5. PubMed ID: 23838030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis.
    Mole SE; Anderson G; Band HA; Berkovic SF; Cooper JD; Kleine Holthaus SM; McKay TR; Medina DL; Rahim AA; Schulz A; Smith AJ
    Lancet Neurol; 2019 Jan; 18(1):107-116. PubMed ID: 30470609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.